Bone marrow endothelial cells produce osteoprotegerin: Evidence for a role in the development of myeloma bone disease
Main Authors: | De Leenheer, E, Vanderkerken, K, Mueller, G, Shipman, C, Bakkus, M, Van Camp, B, Croucher, P |
---|---|
Format: | Conference item |
Published: |
2004
|
Similar Items
-
Bone marrow endothelial cells express the osteoclastogenic factor RANKL and its decoy receptor OPG: Evidence for a role in the development of myeloma bone disease.
by: De Leenheer, E, et al.
Published: (2002) -
Bisphosphonates and osteoprotegerin as inhibitors of myeloma bone disease.
by: Croucher, P, et al.
Published: (2003) -
Osteoprotegerin and the development of myeloma bone disease
by: Croucher, P, et al.
Published: (2004) -
Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma
by: Croucher, P, et al.
Published: (2001) -
Recombinant osteoprotegerin decreases tumor burden and increases survival in a murine model of multiple myeloma.
by: Vanderkerken, K, et al.
Published: (2003)